I agree Vin The proposed range of uses for Oraline IV is very exciting.
And dont forget they will be adding other SBN products later on to their list.
Now that the FDA have an office in China, I bet they get the FDA approval once the 100,000 tests or trials are completed in China, what better proof or data will FDA receive than that.
It's a possible back door entry to FDA approval.
China's stamp of approval will go a long way.
SBN Price at posting:
0.4¢ Sentiment: ST Buy Disclosure: Held